• The lancet oncology · Dec 2022

    Comment

    Fluorouracil and dose-dense adjuvant chemotherapy in breast cancer: lessons learned from the 20-year-old GIM2 trial.

    • Stefania Morganti and Sara M Tolaney.
    • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Gerstner Center for Cancer Diagnostics, Broad Institute ... more of MIT and Harvard, Boston, MA, USA; Division of New Drugs and Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. less
    • Lancet Oncol. 2022 Dec 1; 23 (12): 148214841482-1484.

    no abstract available

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,704,841 articles already indexed!

We guarantee your privacy. Your email address will not be shared.